IGM Biosciences Inc
IGMS
Get informed when a big investor buys or sells
+ FollowMarket Cap$77.5M
Close$
$-0.31
124.7% downside
Current Fair Value
124.7% downsideOvervalued by 124.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $77.50 Million |
|---|---|
| Enterprise Value | $49.25 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.24 |
| Beta | 0.59 |
| Outstanding Shares | 61,462,957 |
Return
| Return on Equity | -52.89% |
|---|---|
| Return on Assets | -49.90% |
| Return on Invested Capital | -39.62% |
Valuation & Multiples
| P/E Ratio | 9.7 |
|---|---|
| PEG | -3.19 |
| Price to Sales | 0.64 |
| Price to Book Ratio | 1.27 |
| Enterprise Value to Revenue | 0.34 |
| Enterprise Value to EBIT | -1.23 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2.99% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 25.97%▼ 3.17% |
|---|---|
| Total Invested | $17.88M▼ 12.76% |
| Investors Holding | 66▼ 14.00% |
ESG Score
No data